Site icon OncologyTube

Metastases Treated with Anti-CTLA-4 & Anti-PD-1 Shows immunotherapies to affect brain metastases

Omid Hamid MD
Chief, Translational Research/Immuno-Oncology
Director explains, Metastases Treated with Anti-CTLA-4 & Anti-PD-1 Shows immunotherapies to affect brain metastases at the 2018 Oncology Summit in Huntington Beach, CA

Go to: http://www.moasc.org for more information

Exit mobile version